MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401

MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401 is an FDA 510(k)-cleared medical device (K003455) manufactured by Chad Therapeutics, Inc.. This device is classified under the Anesthesiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on December 5, 2000. Regulation: 8.